Drug Profile


Alternative Names: Beta-galactosido sorbitol; Emportal; Floralac®; Importal; Lactite; Lactitol monohydrate; Lactositol; Oponaf; Portolac; β-galactosido sorbitol

Latest Information Update: 30 Sep 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novartis Consumer Health
  • Class Osmotic laxatives; Small molecules; Sugar alcohols
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Constipation; Hyperammonaemia

Most Recent Events

  • 30 Dec 1997 Launched for Constipation in Argentina (PO)
  • 19 Nov 1996 Launched for Hyperammonaemia in Spain (PO)
  • 23 Aug 1995 Launched for Constipation in Austria (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top